Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 -2.50%57 5-Year Yield-on-Cost % is 1.85 as of Sep. 15, 2026, which is 34% below its 10-year median of 2.81. GuruFocus rates XKLS:0243 with a GF Score™ of 57/100 and a GF Value™ of RM0.26 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Cengild Medical Bhd ranks worse than 66.55% on this metric.
Cengild Medical Bhd's yield on cost for the quarter that ended in Jun. 2026 was 1.85.
The historical rank and industry rank for Cengild Medical Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:0243'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.76 Med: 2.81 Max: 4.88
Current: 1.85
During the past 6 years, Cengild Medical Bhd's highest Yield on Cost was 4.88. The lowest was 0.76. And the median was 2.81.
XKLS:0243's 5-Year Yield-on-Cost % is ranked worse than 66.55% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.96
vs XKLS:0243: 1.85
Cengild Medical Bhd (XKLS:0243) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Cengild Medical Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:0243 vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Cengild Medical Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's 5-Year Yield-on-Cost % falls into.
Cengild Medical Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Cengild Medical Bhd (XKLS:0243) has a 5-Year Yield-on-Cost % of 1.85 as of Sep. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cengild Medical Bhd and its competitors. This is 34% below median its historical median of 2.81. Over the past decade, Cengild Medical Bhd's 5-Year Yield-on-Cost % has ranged from 0.76 to 4.88. According to the industry distribution chart, Cengild Medical Bhd ranks #187 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 66.5%.
Is Cengild Medical Bhd's 5-Year Yield-on-Cost % too high?
Cengild Medical Bhd's current 5-Year Yield-on-Cost % of 1.85 is 34% below median its 10-year median of 2.81. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 4.88. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.96. Cengild Medical Bhd's value of 1.85 is 37.5% below this industry median. Based on the distribution chart, Cengild Medical Bhd ranks #187 out of 281 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #187 out of 281 companies for 5-Year Yield-on-Cost %. This places Cengild Medical Bhd in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.96. Cengild Medical Bhd's value of 1.85 is 37.5% below this benchmark. Historically, Cengild Medical Bhd's own 5-Year Yield-on-Cost % has ranged from 0.76 to 4.88 over the past decade. While the company's 10-year median is 2.81 vs. the industry median of 2.96, Cengild Medical Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.96, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cengild Medical Bhd's current 5-Year Yield-on-Cost % of 1.85 is 37.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current 5-Year Yield-on-Cost % is 1.85, which is 34% below median its own 10-year median of 2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.26, compared to a current price of RM0.20 — trading 25% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.85, which is 34% below median its 10-year median of 2.81 and 37.5% below the Healthcare Providers & Services industry median of 2.96. Cengild Medical Bhd's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current 5-Year Yield-on-Cost % is 1.85 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 25% below its estimated GF Value™ of RM0.26.
GuruFocus considers Cengild Medical Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0243:
5-Year Yield-on-Cost %: 1.85 (34% below median its 10-year median of 2.81)
GF Value™: RM0.26 vs. price of RM0.20 (25% below fair value)
Industry Position: 37.5% below the Healthcare Providers & Services median (#187 of 281)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
57GF Score
Get the complete analysis for XKLS:0243
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
